| Undifferentiated Carcinoma studied in …STUDIED_INderived162 of 162show fewer |
|---|
| → studied in | NCT02446600Phase 3 · active not recruiting Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02502266Phase 2/Phase 3 · active not recruiting Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05256225Phase 3 · recruiting Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05112601Phase 2 · recruiting Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Sinonasal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06176989Phase 2 · recruiting Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Sinonasal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06235216Phase 2 · recruiting Sacituzumab govitEcan in THYroid Cancers · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04723095recruiting Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Cervical Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07181720Phase 1 · suspended CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101775Phase 2 · active not recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Ovarian Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05557045Phase 1 · active not recruiting A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06902376Phase 1 · recruiting XL092 and Cemiplimab in BRAF WT Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05198830Phase 2 · active not recruiting Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07485569Phase 1 · active not recruiting Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06940180Phase 2 · recruiting Toripalimab With Chemotherapy for Sinus Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Sinonasal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02839707Phase 2/Phase 3 · active not recruiting Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03660826Phase 2 · active not recruiting Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00334815Phase 2 · active not recruiting Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02068794Phase 1/Phase 2 · active not recruiting MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07440290Phase 2/Phase 3 · recruiting DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05453799Phase 2 · suspended Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04675710Phase 2 · active not recruiting Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04171622Phase 2 · active not recruiting Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01386385Phase 1/Phase 2 · active not recruiting Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04739800Phase 2 · active not recruiting Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914612Phase 3 · active not recruiting Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07470489Phase 2 · not yet recruiting Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03181100Phase 2 · active not recruiting Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03120624Phase 1 · active not recruiting VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04092270Phase 1 · active not recruiting A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00707473Phase 2 · terminated Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Sinonasal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04719273Phase 2 · completed Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02186847Phase 2 · completed Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03085056early Phase 1 · active not recruiting Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06996249recruiting Prospective Data Collection Initiative on Thoracic Malignancies · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04238624Phase 2 · active not recruiting Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790706Phase 2 · active not recruiting IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01642251Phase 1/Phase 2 · completed Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03110978Phase 2 · active not recruiting Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Anal Canal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00951496Phase 3 · completed Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07068542NA · recruiting Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer · condition mapped PROBABILISTIC · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01167712Phase 3 · active not recruiting Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Ovarian Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03449108Phase 2 · active not recruiting LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04759911Phase 2 · active not recruiting Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05925491Phase 2 · recruiting Pembrolizumab in Locally Advanced Sinonasal Carcinoma · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Sinonasal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05696548Phase 2 · active not recruiting Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION) · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03975231Phase 1 · recruiting Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01345851NA · active not recruiting Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05566223Phase 1/Phase 2 · withdrawn CISH Inactivated TILs in the Treatment of NSCLC · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06639191early Phase 1 · recruiting [177Lu]Lu-AKIR001 First-in-human Study · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00565851Phase 3 · active not recruiting Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06612827recruiting Development of Tumor Organoids From Undifferentiated Primary Carcinomas to Guide Therapeutic Decisions · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02364713Phase 2 · terminated MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05768178Phase 2/Phase 3 · recruiting DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05668585Phase 1 · completed A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02111941early Phase 1 · completed Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06374602Phase 2 · recruiting Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07138261not yet recruiting Taiwanese Anaplastic Thyroid Cancer Registry · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04400474Phase 2 · completed Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04552769Phase 2 · completed Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06393751Phase 1/Phase 2 · withdrawn Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03845296Phase 2 · completed Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04579757Phase 1/Phase 2 · terminated Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04420754Phase 1 · active not recruiting Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02152137Phase 2 · completed Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02264210Phase 2 · completed Icotinib for Completed Resected IB NSCLC With EGFR Mutation · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02020707Phase 1 · completed Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03565536Phase 2 · completed Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06362694Phase 2 · unknown Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05390021NA · withdrawn PET/MRI in Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04731740Phase 2 · withdrawn Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04739566Phase 2 · withdrawn Dabrafenib and Trametinib Combination as a Neoadjuvant Strategy in BRAF-positive Anaplastic Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02923739Phase 2 · terminated Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02244463Phase 1/Phase 2 · completed A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03641287NA · terminated The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06079333Phase 2 · recruiting NEO- and Adjuvant Targeted Therapy in Braf-mutated Anaplastic Cancer of the Thyroid (NEO-ATACT Study) · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01586767NA · unknown Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Sinonasal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05102292Phase 1/Phase 2 · unknown The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 Mutation · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01992861terminated MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Cervical Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946712Phase 3 · terminated S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05819593unknown Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05796960unknown European Multicenter Study on Surgical Management of Advanced Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492778Phase 2 · unknown Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01097746Phase 2 · completed First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02404441Phase 1/Phase 2 · completed Phase I/II Study of PDR001 in Patients With Advanced Malignancies · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01236547Phase 2 · completed Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02535325Phase 1 · completed Methoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03122496Phase 1 · completed Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02728258Phase 2 · completed Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02688608Phase 2 · completed Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00888615Phase 2 · completed Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00989651Phase 1 · completed Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02853318Phase 2 · completed Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00108745Phase 3 · unknown Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02065687Phase 2/Phase 3 · unknown Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01774279unknown interNational Anaplastic Thyroid Cancer Tissue Bank and Database (iNATT) · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03896958unknown The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01958372Phase 1 · completed Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02283658Phase 2 · completed Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Ovarian Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01935973Phase 1 · completed Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04574817Phase 2 · unknown Study of HX008 for the Treatment of Anaplastic Thyroid Cancer (ATC) · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00603941Phase 1/Phase 2 · terminated A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00950365Phase 2 · completed Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02726503Phase 2 · completed Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03211117Phase 2 · completed Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03305133completed Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC) · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00625846Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02134912Phase 2 · terminated S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00654238Phase 2 · completed Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02657369Phase 2 · terminated A Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC) · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01504126early Phase 1 · completed Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01074411Phase 1 · completed Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02289144Phase 2 · withdrawn Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00262847Phase 3 · completed Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01459380Phase 1 · completed Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Ovarian Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01489371Phase 1 · completed EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Ovarian Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00939809Phase 2 · completed A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Ovarian Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02345460Phase 2 · terminated Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Pancreatic Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01557959Phase 2 · completed Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00955305Phase 2 · terminated Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00899093terminated YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01275664NA · terminated Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Ovarian Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01080521completed Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Ovarian Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01440998Phase 1 · completed Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01642082Phase 2 · completed Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00719303Phase 3 · unknown Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Fallopian Tube Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126568Phase 2 · terminated Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01178944Phase 2 · completed Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer · condition mapped CURATED_BROADER · 162 trials mapped (50 active) | — | — | Esophageal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00888173Phase 2 · completed Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00570674Phase 1/Phase 2 · terminated Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01225887Phase 2 · completed Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00575952Phase 1 · completed Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (50 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004221Phase 2 · terminated Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Ovarian Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01240590Phase 1/Phase 2 · completed A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01294306Phase 2 · completed MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02516774Phase 1 · withdrawn A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00368992Phase 2 · completed S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01093222Phase 2 · completed Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Gallbladder Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00060359Phase 1 · completed Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Ovarian Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02016833completed Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Ovarian Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02059967Phase 1 · withdrawn Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049543Phase 3 · completed Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00814086Phase 1 · completed Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Ovarian Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01294293Phase 1 · completed TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Ovarian Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01668823Phase 1 · completed Photodynamic Therapy in Treating Patients With Lung Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00507429Phase 2/Phase 3 · terminated Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01701349Phase 3 · withdrawn Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00369551Phase 1 · terminated Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095693Phase 2 · terminated Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002852Phase 3 · completed Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00040794Phase 2 · completed Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118183Phase 2 · completed Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087412Phase 2 · completed S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020709Phase 3 · completed Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00021060Phase 2/Phase 3 · completed Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042835Phase 1 · terminated Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005838Phase 3 · completed Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068497NA · completed Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00280852completed Review of Multimodality Management of Anaplastic Thyroid Cancer · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00868504unknown Measuring Temperatures of Tissues During Endoscopy · condition mapped ALIAS · 162 trials mapped (50 active) | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |